Page last updated: 2024-10-29

ifosfamide and Bronchiolitis, Exudative

ifosfamide has been researched along with Bronchiolitis, Exudative in 1 studies

Research Excerpts

ExcerptRelevanceReference
" ifosfamide and etoposide) and to improve overall survival of previously untreated patients with metastatic rhabdomyosarcoma."9.09Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. ( Breitfeld, PP; Crist, WM; Donaldson, SS; Lobe, T; Lyden, E; Maurer, HM; Raney, RB; Ruymann, FB; Teot, LA; Wharam, M, 2001)
" ifosfamide and etoposide) and to improve overall survival of previously untreated patients with metastatic rhabdomyosarcoma."5.09Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. ( Breitfeld, PP; Crist, WM; Donaldson, SS; Lobe, T; Lyden, E; Maurer, HM; Raney, RB; Ruymann, FB; Teot, LA; Wharam, M, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breitfeld, PP1
Lyden, E1
Raney, RB1
Teot, LA1
Wharam, M1
Lobe, T1
Crist, WM1
Maurer, HM1
Donaldson, SS1
Ruymann, FB1

Trials

1 trial available for ifosfamide and Bronchiolitis, Exudative

ArticleYear
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bronchiolit

2001